期刊
POLYMERS
卷 15, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/polym15092031
关键词
nicotinamide mononucleotide; transdermal delivery; patch; polyvinyl alcohol; carboxymethyl cellulose
Nicotinamide mononucleotide (NMN) is a precursor of nicotinamide adenine dinucleotide that plays a crucial role in intracellular redox reactions. Oral NMN capsules currently have low bioavailability due to metabolism and excretion. To address this issue, PVA-based microneedle patches were developed for transdermal delivery of NMN. The optimal molecular weight PVA microneedle containing NMN and CMC achieved a high release rate of 91.94% in 18 hours.
Nicotinamide mononucleotide (NMN), which has recently been spotlighted as an anti-aging agent, is a precursor of the coenzyme nicotinamide adenine dinucleotide that plays an important role in intracellular redox reactions. NMN capsules for oral administration currently on the market have a problem in that they are almost fully metabolized in the stomach and liver and excreted as nicotinamide. Therefore, there is a need to develop a patient-friendly delivery method that can improve the bioavailability of NMN. For this purpose, various polyvinyl alcohol (PVA)-based microneedle patches were fabricated to develop a transdermal delivery system for NMN. First, the molecular weight effect of PVA on the shape and microstructure of microneedles was studied. After selecting the optimal molecular weight PVA, the swelling of the microneedles and the ex vivo release of NMN were studied. The effect of carboxymethyl cellulose (CMC) and dimethyl sulfoxide on NMN release was also investigated. The highest NMN release of 91.94% in 18 h was obtained using a 9.5 kDa molecular weight PVA microneedle containing NMN and CMC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据